Ultragenyx to Present at Cowen and Company 34th Annual Health Care Conference in Boston

[GlobeNewswire] – Novato, CA — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini Sharp, … more

View todays social media effects on RARE

View the latest stocks trending across Twitter. Click to view dashboard

See who Ultragenyx is hiring next, click here to view